197 Determination of fees
(1) The Minister may determine fees for this Act.
(2) A determination is a disallowable instrument.
(see ch 9)
item
1 85 issue licence for less than
maximum period
applicant for licence
2 85 (2) refuse to issue licence applicant for licence
3 90 (1) issue licence subject to condition
included by chief health officer
applicant for licence
4 91 amend licence licence-holder
5 92 amend licence in terms different
from application or refuse to
amend licence
licence-holder
6 142 (3) • reprimand authorisation
holder
• require authorisation holder
or employee to complete
training
• impose condition on
authorisation holder’s
authority to deal with
• amend authorisation
authorisation holder
Reviewable decisions Schedule 1
item
• suspend authorisation
therapeutic good or deal
therapeutic good in
particular way
• period of suspension/course
of training/stated event
• cancel authorisation
• prohibit interstate
wholesaler from supplying
therapeutic good by
wholesale in ACT
7 142 (3) • reprimand former
authorisation holder
• disqualify former
authorisation holder from
being authorised to deal
therapeutic good or deal
therapeutic good in
particular way
• period of
disqualification/course of
training/stated event
former authorisation
holder
item
• prohibit former interstate
wholesaler from supplying
therapeutic good by
wholesale in ACT
8 191 give direction person to whom
direction is given
(see s 3)
Note 1 The Legislation Act contains definitions and other provisions relevant to
this Act.
Note 2 For example, the Legislation Act, dict, pt 1, defines the following terms:
• ACAT
• bankrupt or personally insolvent
• chief health officer
• contravene
• corporation
• dentist
• doctor
• found guilty
• function
• health practitioner
• home address
• midwife
• Minister (see s 162)
• optometrist
• pharmacist
• reviewable decision notice
• territory-owned corporation
• under
• veterinary practitioner.
another jurisdiction, for chapter 6A (Monitored medicines
applied provisions, for chapter 10 (Incorporation of Commonwealth
therapeutic goods laws)—see section 156.
applies, in relation to a substance for a schedule or appendix of the
medicines and poisons standard—see section 17.
approved data source entity, for chapter 6A (Monitored medicines
at premises includes in or on the premises.
authorisation holder, for part 8.1 (Authorisations—disciplinary
action)—see section 139.
authorised—
(a) to deal with a regulated substance—see section 20; and
(b) to deal with a regulated therapeutic good—see section 22.
business includes—
(a) a business not carried on for profit; and
(b) a trade or profession.
close associate, of someone, for chapter 6 (Licences for regulated
substances and regulated therapeutic goods)—see section 79.
Commonwealth administrative laws, for chapter 10 (Incorporation
of Commonwealth therapeutic goods laws)—see section 156.
Commonwealth Minister, for chapter 10 (Incorporation of
Commonwealth therapeutic goods laws)—see section 156.
Commonwealth Secretary, for chapter 10 (Incorporation of
Commonwealth therapeutic goods laws)—see section 156.
Commonwealth therapeutic goods laws, for chapter 10
(Incorporation of Commonwealth therapeutic goods laws)—see
section 156.
community pharmacy means a pharmacy at a place other than an
institution.
connected, with an offence, for part 7.1 (Inspection and seizure
powers)—see section 98.
controlled medicine—see section 11.
Section 197 - Medicines, Poisons and Therapeutic Goods Act 2008 - Determination of fees | Zoe
corresponding law means—
(a) a law of a State corresponding, or substantially corresponding,
to this Act; or
(b) a law of the Commonwealth, a State or New Zealand that is
declared by regulation to be a corresponding law, whether or not
the law corresponds, or substantially corresponds, to this Act.
Note State includes a territory (see Legislation Act, dict, pt 1).
dangerous poison—see section 12.
day hospital means a facility where a person is admitted for surgical
or medical treatment and discharged on the same day.
deals—
(a) with a regulated substance—see section 19; and
(b) with a regulated therapeutic good—see section 21.
declared substance, for part 4.1 (Dealings with regulated
substances—offences)—see section 25.
disciplinary action, for part 8.1 (Authorisations—disciplinary
action)—see section 141.
disciplinary notice, for part 8.1 (Authorisations—disciplinary
action)—see section 142 (1).
dispense means supply on prescription.
dosage unit means an individual dose of a medicine or poison for
therapeutic use and includes a tablet, capsule, cachet, single-dose
powders or single-dose sachet or powders or granules.
drug offence, for part 8.2 (Controlled medicines and prohibited
substances—disqualification by courts)—see section 147.
executive officer, of a corporation, means a person, however
described and whether or not the person is a director of the
corporation, who is concerned with, or takes part in, the corporation’s
management.
ground for disciplinary action, against an authorisation holder, for
part 8.1 (Authorisations—disciplinary action)—see section 140 (1).
hospital—
(a) means a public hospital, private hospital or day hospital; and
Note A hospice is a hospital (see The Macquarie Dictionary, 3rd ed,
def hospice).
(b) includes a body prescribed by regulation as a hospital.
influential person, for a corporation, for chapter 6 (Licences for
regulated substances and regulated therapeutic goods)—see
section 80.
institution—
(a) means a hospital, residential aged care facility, residential
disability care facility or other institution used for the
accommodation, treatment and care of people suffering from
mental or physical conditions; and
Note Hospital, residential aged care facility and residential disability
care facility are defined in this dictionary.
(b) includes a body prescribed by regulation as an institution.
interstate wholesaler, for part 8.1 (Authorisations—disciplinary
action)—see section 139.
licence, for chapter 6 (Licences for regulated substances and
regulated therapeutic goods)—see section 78.
low harm poison—see section 12.
manufacture, for a regulated substance, means do 1 or more of the
following in relation to the substance:
(a) carry out a process to produce the substance;
(b) refine the substance;
(c) convert the substance into another regulated substance;
(d) make or prepare an ampoule, capsule, tablet, vial or other dosage
form that consists of, or contains, the substance;
(e) mix, compound or formulate the substance with another
regulated substance or any other substance;
(f) pack or repack the substance for sale by wholesale or for use in
connection with a business, industry, profession or trade.
medicine—see section 11.
medicines advisory committee means the Medicines Advisory
Committee established under section 194.
medicines and poisons inspector—see section 99.
medicines and poisons standard—see section 15.
moderate harm poison—see section 12.
monitored medicine—see section 97A.
monitored medicines database, for chapter 6A (Monitored medicines
must keep, a register for a regulated substance, for division 4.2.2
(Registers for regulated substances)—see section 48.
occupier, of premises, for part 7.1 (Inspection and seizure powers)—
see section 98.
offence, for part 7.1 (Inspection and seizure powers)—see section 98.
opioid dependency treatment centre means a facility—
(a) licensed under this Act to treat opioid dependency; or
(b) operated by the Territory where treatment, including the supply
and administration of controlled medicines, is provided to
drug-dependent people for their drug dependency.
pharmacist only medicine—see section 11.
pharmacy medicine—see section 11.
poison—see section 12.
possess, for a regulated substance—see section 24.
premises includes land or a structure or vehicle and any part of an
area of land or a structure or vehicle.
prescribe a medicine means issue a prescription for the medicine.
prescription, in relation to a medicine, means an oral or written
direction (other than a purchase order, requisition or standing order)
to a person—
(a) who is authorised to administer the medicine to administer the
medicine; or
(b) who is authorised to dispense the medicine to dispense the
medicine.
prescription only medicine—see section 11.
prohibited substance—see section 13.
purchase order means a written order for the supply of a regulated
register, for a regulated substance, means a register that a person is
required to keep under section 48 for the substance.
regulated substance—see section 10.
regulated therapeutic good—see section 14.
regulated thing, for chapter 12 (Regulations about regulated
substances and regulated therapeutic goods)—see section 183.
relevant health practitioner, for chapter 6A (Monitored medicines
relevant person, for part 8.2 (Controlled medicines and prohibited
substances—disqualification by courts)—see section 147.
required information, about the supply of a monitored medicine, for
chapter 6A (Monitored medicines database)—see section 31 (4).
requisition means an oral or written request for the supply of a
medicine—
(a) from a pharmacy in an institution to a ward or another pharmacy
in the institution; or
(b) to a pharmacy in an institution from a ward in the institution; or
(c) to a ward in an institution from another ward in the institution;
or
(d) from a pharmacy in an institution to a pharmacy in another
institution.
residential aged care facility means a residential care home within
the meaning of the Aged Care Act 2024 (Cwlth), section 10.
residential disability care facility—
(a) means a residential facility that provides disability care to
people with disabilities; but
(b) does not include a residential aged care facility.
reviewable decision, for chapter 9 (Notification and review of
decisions)—see section 154.
schedule 10 substance—see section 13.
sell—see section 24.
signs—a person signs something if the person signs with the person’s
usual signature, whether electronically or otherwise.
standing order means a written order authorising the supply or
administration of medicines as stated in the order, in stated clinical
circumstances.
suitable person—
(a) for an individual—see section 81; and
(b) for a corporation—see section 82.
supply—see section 24.
supply authority—see section 23.
vending machine, for division 4.3.5 (Vending machines—
offences)—see section 67.
veterinary practitioners board means the veterinary practitioners
board established under the Veterinary Practice Act 2018, section 90.
ward means an area of an institution used to accommodate or treat
people, including an operating theatre and an opioid dependency
treatment centre.
wholesale means supply—
(a) for retail sale; or
(b) for use in connection with a business, industry, profession or
trade.
written includes in electronic form.
About the endnotes 1
1 About the endnotes
Amending and modifying laws are annotated in the legislation history and the
amendment history. Current modifications are not included in the republished law
but are set out in the endnotes.
Not all editorial amendments made under the Legislation Act 2001, part 11.3 are
annotated in the amendment history. Full details of any amendments can be
obtained from the Parliamentary Counsel’s Office.
Uncommenced amending laws are not included in the republished law. The details
of these laws are underlined in the legislation history. Uncommenced expiries are
underlined in the legislation history and amendment history.
If all the provisions of the law have been renumbered, a table of renumbered
provisions gives details of previous and current numbering.
The endnotes also include a table of earlier republications.
2 Abbreviation key
A = Act NI = Notifiable instrument
AF = Approved form o = order
am = amended om = omitted/repealed
amdt = amendment ord = ordinance
AR = Assembly resolution orig = original
ch = chapter par = paragraph/subparagraph
CN = Commencement notice pres = present
def = definition prev = previous
DI = Disallowable instrument (prev...) = previously
dict = dictionary pt = part
disallowed = disallowed by the Legislative r = rule/subrule
Assembly reloc = relocated
div = division renum = renumbered
exp = expires/expired R[X] = Republication No
Gaz = gazette RI = reissue
hdg = heading s = section/subsection
IA = Interpretation Act 1967 sch = schedule
ins = inserted/added sdiv = subdivision
LA = Legislation Act 2001 SL = Subordinate law
LR = legislation register sub = substituted
LRA = Legislation (Republication) Act 1996 underlining = whole or part not commenced
mod = modified/modification or to be expired
Medicines, Poisons and Therapeutic Goods Act 2008 A2008-26
notified LR 14 August 2008
s 1, s 2 commenced 14 August 2008 (LA s 75 (1))
remainder commenced 14 February 2009 (s 2 and LA s 79)
as amended by
ACT Civil and Administrative Tribunal Legislation Amendment
Act 2008 A2008-36 sch 1 pt 1.37
notified LR 4 September 2008
s 1, s 2 commenced 4 September 2008 (LA s 75 (1))
sch 1 pt 1.37 commenced 14 February 2009 (s 2 (5) and see A2008-26
s 2 and LA s 79)
as modified by
Medicines, Poisons and Therapeutic Goods Regulation 2008
SL2008-42 (as am by SL2009-27 s 6)
notified LR 15 September 2008
s 1, s 2 commenced 15 September 2008 (LA s 75 (1))
remainder commenced 14 February 2009 (s 2 and see Medicines,
Poisons and Therapeutic Goods Act 2008 A2008-26, s 2 and LA s 79)
Medicines, Poisons and Therapeutic Goods Amendment
Regulation 2009 (No 1) SL2009-27 s 6
notified LR 5 June 2009
s 1, s 2 commenced 5 June 2009 (LA s 75 (1))
s 6 commenced 6 June 2009 (s 2)
Note This regulation only amends the Medicines, Poisons and
Therapeutic Goods Regulation 2008 SL2008-42.
as amended by
Statute Law Amendment Act 2009 A2009-20 sch 3 pt 3.52
notified LR 1 September 2009
s 1, s 2 commenced 1 September 2009 (LA s 75 (1))
sch 3 pt 3.52 commenced 22 September 2009 (s 2)
Legislation history 3
Statute Law Amendment Act 2009 (No 2) A2009-49 sch 1 pt 1.8, sch 3
pt 3.50
notified LR 26 November 2009
s 1, s 2 commenced 26 November 2009 (LA s 75 (1))
sch 1 pt 1.8, sch 3 pt 3.50 commenced 17 December 2009 (s 2)
Health Practitioner Regulation National Law (ACT) Act 2010 A2010-10
sch 2 pt 2.14
notified LR 31 March 2010
s 1, s 2 commenced 31 March 2010 (LA s 75 (1))
sch 2 pt 2.14 commenced 1 July 2010 (s 2 (1) (a))
Administrative (One ACT Public Service Miscellaneous Amendments)
Act 2011 A2011-22 sch 1 pt 1.113
notified LR 30 June 2011
s 1, s 2 commenced 30 June 2011 (LA s 75 (1))
sch 1 pt 1.113 commenced 1 July 2011 (s 2 (1))
Statute Law Amendment Act 2011 (No 3) A2011-52 sch 1 pt 1.4
notified LR 28 November 2011
s 1, s 2 commenced 28 November 2011 (LA s 75 (1))
sch 1 pt 1.4 commenced 12 December 2011 (s 2)
Directors Liability Legislation Amendment Act 2013 A2013-4 sch 1
pt 1.6
notified LR 21 February 2013
s 1, s 2 commenced 21 February 2013 (LA s 75 (1))
sch 1 pt 1.6 commenced 22 February 2013 (s 2)
Statute Law Amendment Act 2013 (No 2) A2013-44 sch 3 pt 3.14
notified LR 11 November 2013
s 1, s 2 commenced 11 November 2013 (LA s 75 (1))
sch 3 pt 3.14 commenced 25 November 2013 (s 2)
Annual Reports (Government Agencies) Amendment Act 2015
A2015-16 sch 1 pt 1.16
notified LR 27 May 2015
s 1, s 2 commenced 27 May 2015 (LA s 75 (1))
sch 1 pt 1.16 commenced 3 June 2015 (s 2)
Veterinary Surgeons Act 2015 A2015-29 sch 2 pt 2.9
notified LR 20 August 2015
s 1, s 2 commenced 20 August 2015 (LA s 75 (1))
sch 2 pt 2.9 commenced 1 December 2015 (s 2 (1) and CN2015-22)
Statute Law Amendment Act 2015 (No 2) A2015-50 sch 1 pt 1.2
notified LR 25 November 2015
s 1, s 2 commenced 25 November 2015 (LA s 75 (1))
sch 1 pt 1.2 commenced 9 December 2015 (s 2)
Red Tape Reduction Legislation Amendment Act 2016 A2016-18
sch 3 pt 3.30
notified LR 13 April 2016
s 1, s 2 commenced 13 April 2016 (LA s 75 (1))
sch 3 pt 3.30 commenced 27 April 2016 (s 2)
Justice and Community Safety Legislation Amendment Act 2016
A2016-37 sch 1 pt 1.15
notified LR 22 June 2016
s 1, s 2 commenced 22 June 2016 (LA s 75 (1))
sch 1 pt 1.15 commenced 29 June 2016 (s 2)
Work Health and Safety Legislation Amendment Act 2018 A2018-8
sch 1 pt 1.6
notified LR 5 March 2018
s 1, s 2 commenced 5 March 2018 (LA s 75 (1))
sch 1 pt 1.6 commenced 29 March 2018 (s 2)
Medicines, Poisons and Therapeutic Goods Amendment Act 2018
A2018-23 pt 2
notified LR 14 June 2018
s 1, s 2 commenced 14 June 2018 (LA s 75 (1))
pt 2 commenced 15 June 2018 (s 2)
Veterinary Practice Act 2018 A2018-32 sch 3 pt 3.11
notified LR 30 August 2018
s 1, s 2 commenced 30 August 2018 (LA s 75 (1))
sch 3 pt 3.11 commenced 21 December 2018 (s 2 and CN2018-12)
Legislation history 3
Red Tape Reduction Legislation Amendment Act 2018 A2018-33
sch 1 pt 1.25
notified LR 25 September 2018
s 1, s 2 commenced 25 September 2018 (LA s 75 (1))
sch 1 pt 1.25 commenced 23 October 2018 (s 2 (4))
Crimes Legislation Amendment Act 2019 A2019-23 pt 11
notified LR 8 August 2019
s 1, s 2 commenced 8 August 2019 (LA s 75 (1))
pt 11 commenced 15 August 2019 (s 2 (1))
Drugs of Dependence (Personal Cannabis Use) Amendment Act 2019
A2019-34 sch 1 pt 1.2
notified LR 10 October 2019
s 1, s 2 commenced 10 October 2019 (LA s 75 (1))
sch 1 pt 1.2 commenced 31 January 2020 (s 2 (1) and CN2020-1))
Statute Law Amendment Act 2021 A2021-12 sch 3 pt 3.35
notified LR 9 June 2021
s 1, s 2 commenced 9 June 2021 (LA s 75 (1))
sch 3 pt 3.35 commenced 23 June 2021 (s 2 (1))
Health Legislation Amendment Act 2022 A2022-24 pt 2
notified LR 9 December 2022
s 1, s 2 commenced 9 December 2022 (LA s 75 (1))
pt 2 commenced 10 December 2022 (s 2)
Voluntary Assisted Dying Act 2024 A2024-24 sch 3 pt 3.5
notified LR 19 June 2024
s 1, s 2 commenced 19 June 2024 (LA s 75 (1))
sch 3 pt 3.5 commenced 3 November 2025 (s 2)
Health Legislation Amendment Act 2024 A2024-42 pt 5
notified LR 17 September 2024
s 1, s 2 commenced 17 September 2024 (LA s 75 (1))
pt 5 commenced 18 September 2024 (s 2 (1))
Tobacco and Other Smoking Products (Vaping Goods) Amendment
Act 2025 A2025-8 sch 2 pt 2.1
notified LR 17 April 2025
s 1, s 2 commenced 17 April 2025 (LA s 75 (1))
sch 2 pt 2.1 commenced 18 April 2025 (s 2)
Health Legislation Amendment Act 2025 A2025-16 sch 1 pt 1.5
notified LR 26 May 2025
s 1, s 2 commenced 26 May 2025 (LA s 75 (1))
sch 1 pt 1.5 commenced 2 June 2025 (s 2)
Statute Law Amendment Act 2025 A2025-29 sch 3 pt 3.62, sch 4
pt 4.124
notified LR 6 November 2025
s 1, s 2 commenced 6 November 2025 (LA s 75 (1))
sch 3 pt 3.62, sch 4 pt 4.124 commenced 26 November 2025 (s 2 (3),
(9))
Health Legislation Amendment Act 2025 (No 2) A2025-33 pt 4
notified LR 12 November 2025
s 1, s 2 commenced 12 November 2025 (LA s 75 (1))
pt 4 commenced 26 November 2025 (s 2 (1) (a), (3))
Commencement
s 2 om LA s 89 (4)
s 3 am A2015-29 amdt 2.63
Objects
s 6 am A2010-10 amdt 2.79; A2015-29 amdt 2.64; A2018-32
amdt 3.29
Appropriate prescription and supply of medicines
s 7 am A2010-10 amdt 2.80; A2015-29 amdt 2.65; A2018-32
amdt 3.30
Application of Act to certain cannabis use not prohibited under Drugs of
Dependence Act 1989
s 9A ins A2019-34 amdt 1.3
Meaning of regulated substance—Act
s 10 am A2015-50 amdt 1.9
Meaning of prohibited substance and schedule 10 substance—Act
s 13 sub A2015-50 amdt 1.4
am A2019-23 s 51, s 52
Meaning of regulated therapeutic good—Act
s 14 am A2025-8 amdt 2.1
Meaning of medicines and poisons standard—Act
s 15 am A2025-8 amdt 2.2, amdt 2.3
Interpretation provisions in medicines and poisons standard—application to
Act
s 16 am A2025-33 s 7, s 8
Meaning of deals with a regulated substance—Act
s 19 am A2015-50 amdt 1.9
When authorised to deal with regulated substances
s 20 am A2015-50 amdt 1.9; A2024-24 amdt 3.8; A2025-33 s 9
Meaning of possess, sell and supply—Act
s 24 am A2009-49 amdt 3.118
Meaning of declared substance—pt 4.1
s 25 am A2015-50 amdt 1.9
Supplying declared substances
s 26 am A2025-29 amdt 3.205
Supply of certain declared substances—information for chief health officer
s 31 am A2018-23 s 4
Discarding declared etc substances
s 34 am A2018-8 amdt 1.25, amdt 1.26
Administering certain declared substances
s 37 am A2016-37 amdt 1.31; ss renum R16 LA; A2025-29
amdt 3.205
Reporting loss and theft of certain regulated substances
s 39 am A2015-50 amdt 1.9
Prescribing medicines
s 40 am A2025-29 amdt 3.205
Medicines for animals not to be prescribed etc for human use
s 43 am R29 LA
False statements to obtain certain regulated substances etc
s 64 am A2009-49 amdt 3.119
Advertising controlled medicines and prohibited substances
s 66 am A2018-32 amdt 3.31
Vending machines—use for supply of unscheduled medicines
s 69 am A2025-33 s 10
Paints—offences
div 4.3.6 hdg am A2025-33 s 10
Manufacture, supply and use of paints for certain purposes
s 71 am A2015-50 amdt 1.5, amdt 1.6; A2025-33 s 10
Manufacture, supply and use of paints containing pesticides
s 73 am A2025-33 s 10
Supplying regulated therapeutic goods
s 74 am A2016-37 amdt 1.32, amdt 1.33; ss renum R16 LA;
A2025-29 amdt 3.207
Suitability of individuals for licences
s 81 am A2009-20 amdt 3.132; A2011-52 amdt 1.6
Power to ask for information etc from applicants and others
s 83 am A2009-20 amdt 3.133; A2013-44 amdt 3.105; A2016-18
amdts 3.144-3.146
Applications for licences
s 84 am A2021-12 amdt 3.83; A2025-29 amdt 4.125
Decision on applications for licences
s 85 am A2009-20 amdt 3.134; A2021-12 amdt 3.84
Form of licences
s 88 am A2009-20 amdt 3.135; A2009-49 amdt 1.21
Statutory licence conditions
s 89 am A2009-20 amdt 3.136
Other licence conditions
s 90 am A2009-20 amdt 3.137
Amending licence on application by licence-holder
s 92 am A2021-12 amdt 3.85; A2025-29 amdt 4.125
Licensee to keep chief health officer informed
s 93 hdg sub A2009-49 amdt 1.22
s 93 am A2009-49 amdt 1.22
Replacing licences
s 95 am A2013-44 amdt 3.106; A2016-18 amdt 3.147, amdt 3.148;
A2025-29 amdt 4.125
Surrendering licences
s 97 am A2013-44 amdt 3.107; A2016-18 amdt 3.149, amdt 3.150
Monitored medicines database
ch 6A hdg ins A2018-23 s 5
Meaning of monitored medicine
s 97A ins A2018-23 s 5
Definitions—ch 6A
s 97B ins A2018-23 s 5
def another jurisdiction ins A2018-23 s 5
sub A2024-42 s 10
def approved data source entity ins A2018-23 s 5
def monitored medicines database ins A2018-23 s 5
def relevant health practitioner ins A2018-23 s 5
def required information ins A2018-23 s 5
Monitored medicines database—purposes
s 97C ins A2018-23 s 5
Monitored medicines database—scope
s 97D ins A2018-23 s 5
Monitored medicines database—chief health officer functions
s 97E ins A2018-23 s 5
Monitored medicines database—access and use by relevant health
practitioners
s 97F ins A2018-23 s 5
Monitored medicines database—access authority
s 97G ins A2018-23 s 5
am A2021-12 amdt 3.85; A2025-29 amdt 4.125
Monitored medicines database—offences
s 97H ins A2018-23 s 5
Power to enter premises
s 102 am A2009-20 amdt 3.138; pars renum R3 LA
Production of identity card
s 103 am A2025-29 amdt 3.208
Consent to entry
s 104 am A2025-29 amdt 3.208
Power to require name and address
s 108 am A2025-8 amdt 2.4
Warrants—application made other than in person
s 110 am A2018-33 amdt 1.47, amdt 1.48
Search warrants—announcement before entry
s 111 am A2025-29 amdt 3.209
Procedures for dividing samples
s 135 am A2009-20 amdt 3.139
Certificates of analysis by authorised analysts
s 137 am A2021-12 amdt 3.85
Application—pt 8.1
s 138 am A2010-10 amdt 2.81; A2015-29 amdt 2.66; A2018-32
amdt 3.32
Disciplinary action against authorisation holders
s 141 am A2018-23 s 6, s 7
Taking disciplinary action against authorisation holders
s 142 am A2025-29 amdt 3.210
Effect of suspension of authorisations
s 144 am A2018-23 s 8
Return of certain licences and approvals
s 145 am A2018-23 s 8, s 9
Action by chief health officer in relation to certain licences and approvals
s 146 am A2018-23 s 10
Notice of disqualification from dealing
s 149 am A2010-10 amdt 2.82; A2015-29 amdt 2.67; A2018-32
amdt 3.33
Surrender of authorisation under regulation
s 152 am A2010-10 amdt 2.82; A2015-29 amdt 2.68; A2018-32
amdt 3.33
Notification and review of decisions
ch 9 hdg sub A2008-36 amdt 1.491
Meaning of reviewable decision—ch 9
s 154 sub A2008-36 amdt 1.491
Reviewable decision notices
s 155 sub A2008-36 amdt 1.491
Applications for review
s 155A ins A2008-36 amdt 1.491
Definitions—ch 10
s 156 def Commonwealth administrative laws am A2025-16
amdt 1.32
Application of Commonwealth therapeutic goods laws to ACT
s 157 am A2022-24 s 4
Criminal liability of executive officers
s 172 sub A2013-4 amdt 1.7
am A2025-29 amdt 3.211
Notices of noncompliance by territory entities
s 177 am A2011-22 amdts 1.331-1.333; A2015-16 amdt 1.20,
amdt 1.21; ss renum R12 LA; A2025-29 amdt 3.212
Regulation-making power
s 184 am A2025-29 amdt 4.125
Regulations—authorisations
s 186 am A2009-20 amdt 3.140
Regulations—application etc of instruments
s 189 am A2025-29 amdt 4.125
Regulations—exemption of people, dealings etc
s 190 am A2013-44 amdt 3.108; A2025-29 amdt 4.125
Guidelines about dealings with regulated substances and therapeutic goods
s 192 am A2025-29 amdt 4.125
Approval of non-standard packaging and labelling
s 193 am A2025-29 amdt 4.125
Secrecy
s 195 am A2010-10 amdt 2.83; A2015-29 amdt 2.69; A2018-32
amdt 3.34
Determination of fees
s 197 am A2025-29 amdt 4.125
Approved forms
s 198 om A2021-12 amdt 3.86
Transitional
ch 14 hdg exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—general
pt 14.1 hdg exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Definitions—ch 14
s 500 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional regulations
s 501 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional effect—Legislation Act, s 88
s 502 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Expiry—ch 14
s 503 exp 14 February 2011 (s 503)
Consequential and other amendments and repeals
pt 14.2 hdg om LA s 89 (3)
Legislation amended—sch 2
s 510 om LA s 89 (3)
Legislation repealed
s 511 om LA s 89 (3)
Transitional—licences and authorisations
pt 14.3 hdg exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—existing licences
s 520 am A2009-20 amdt 3.141
Transitional—uncompleted licence applications
s 521 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—existing authorisations
s 522 am A2009-20 amdt 3.141
Transitional—uncompleted authorisation applications
s 523 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—uncompleted applications for ACAT review
s 524 sub A2008-36 amdt 1.492
Transitional—approvals to prescribe drugs of dependence
pt 14.4 hdg exp 14 February 2011 (s 503 (LA s 88 declaration applies)))
Transitional—meaning of drugs advisory committee—pt 14.4
s 530 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—existing approvals to prescribe drugs of dependence
s 531 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—uncompleted applications to prescribe drugs of dependence
s 532 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—uncompleted applications for drugs advisory committee
review
s 533 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—supply authorities
pt 14.5 hdg exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—prescriptions generally
s 540 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—requisitions generally
s 541 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—purchase orders generally
s 542 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—standing orders
s 543 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—other
pt 14.6 hdg exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—registers
s 550 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Transitional—drugs advisory committee members
s 551 exp 14 February 2011 (s 503 (LA s 88 declaration applies))
Modification—Crimes Act 1900
s 552 ins as mod SL2008-42 s 1100 (as ins by SL2009-27 s 6)
mod lapsed 21 December 2010 (SL2008-42 s 1100 om by
A2010-50 amdt 1.13)
Reviewable decisions
sch 1 sub A2008-36 amdt 1.493
am A2018-23 s 11
Consequential and other amendments
sch 2 om LA s 89 (3)
dict am A2008-36 amdt 1.494; A2009-49 amdt 3.120; A2010-10
amdt 2.84; A2011-52 amdt 1.7; A2013-44 amdt 3.109;
A2015-29 amdt 2.70; A2018-32 amdt 3.35; A2025-29
amdt 3.213
def another jurisdiction ins A2018-23 s 12
def appendix C substance om A2015-50 amdt 1.7
def approved data source entity ins A2018-23 s 12
def chief pharmacist reloc to Medicines, Poisons and
Therapeutic Goods Regulation 2008 dict by A2013-44
amdt 3.110
def declared substance am A2013-44 amdt 3.111
def drug-dependent person reloc to Medicines, Poisons and
Therapeutic Goods Regulation 2008 dict by A2013-44
amdt 3.112
def health professional om A2015-29 amdt 2.71
def medicines advisory committee am A2013-44 amdt 3.113
def monitored medicine ins A2018-23 s 12
def monitored medicines database ins A2018-23 s 12
def prescribe sub A2013-44 amdt 3.114
def relevant health practitioner ins A2018-23 s 12
def required information ins A2018-23 s 12
def residential aged care facility sub A2025-33 s 11
def reviewable decision ins A2008-36 amdt 1.495
def schedule 10 substance ins A2015-50 amdt 1.8
def vending machine am A2013-44 amdt 3.115
def veterinary practitioners board ins A2018-32 amdt 3.36
def veterinary surgeons board ins A2015-29 amdt 2.72
om A2018-32 amdt 3.37
Earlier republications 5
5 Earlier republications
Some earlier republications were not numbered. The number in column 1 refers to
the publication order.
Since 12 September 2001 every authorised republication has been published in
electronic pdf format on the ACT legislation register. A selection of authorised
republications have also been published in printed format. These republications are
marked with an asterisk (*) in column 1. Electronic and printed versions of an
authorised republication are identical.
for
14 Feb 2009
14 Feb 2009–
A2008-36 new Act and
amendments by
A2008-36
6 June 2009–
21 Sept 2009
SL2009-27 modifications by
SL2008-42 as
amended by
SL2009-27
22 Sept 2009
22 Sept 2009–
16 Dec 2009
A2009-20 amendments by
A2009-20
17 Dec 2009
17 Dec 2009–
A2009-49 amendments by
A2009-49
1 July 2010–
20 Dec 2010
A2010-10 amendments by
A2010-10
21 Dec 2010
21 Dec 2010–
14 Feb 2011
A2010-10 lapsed modification
(s 552)
15 Feb 2011
15 Feb 2011–
A2010-10 expiry of
transitional
provisions (ch 14)
1 July 2011–
11 Dec 2011
A2011-22 amendments by
A2011-22
12 Dec 2011
12 Dec 2011–
21 Feb 2013
A2011-52 amendments by
A2011-52
22 Feb 2013
22 Feb 2013–
24 Nov 2013
A2013-4 amendments by
A2013-4